Editas Medicine, Inc.
EDIT
$2.35
-$0.11-4.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.40% | -24.90% | -41.97% | -48.37% | -58.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.40% | -24.90% | -41.97% | -48.37% | -58.64% |
| Cost of Revenue | -54.85% | -49.52% | -34.75% | -6.14% | 12.16% |
| Gross Profit | 70.39% | 59.11% | 31.44% | -18.44% | -67.73% |
| SG&A Expenses | -30.68% | -21.66% | -9.42% | 0.06% | 3.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.44% | -42.79% | -28.69% | -4.53% | 9.68% |
| Operating Income | 58.42% | 47.63% | 24.51% | -11.89% | -41.22% |
| Income Before Tax | 32.49% | 5.10% | -22.44% | -51.22% | -54.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 32.49% | 5.10% | -22.44% | -51.22% | -54.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.49% | 5.10% | -22.44% | -51.22% | -54.74% |
| EBIT | 58.42% | 47.63% | 24.51% | -11.89% | -41.22% |
| EBITDA | 59.34% | 49.67% | 26.51% | -11.07% | -41.81% |
| EPS Basic | 34.61% | 7.29% | -20.76% | -44.57% | -39.94% |
| Normalized Basic EPS | 58.85% | 43.91% | 18.79% | -15.22% | -34.01% |
| EPS Diluted | 34.61% | 7.29% | -20.76% | -44.57% | -39.94% |
| Normalized Diluted EPS | 58.85% | 43.91% | 18.79% | -15.22% | -34.01% |
| Average Basic Shares Outstanding | 7.73% | 3.57% | 1.51% | 4.35% | 8.46% |
| Average Diluted Shares Outstanding | 7.73% | 3.57% | 1.51% | 4.35% | 8.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |